On February 18, 2020 Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) reported that it will release its fourth quarter and full year 2019 financial results, as well as its 2020 financial guidance, on Thursday, Feb. 27, after the close of the U.S. financial markets (Press release, Mylan, FEB 18, 2020, View Source [SID1234554472]). The company also will host a webcast at 4:30 p.m. ET on Feb. 27 to discuss the results and 2020 guidance.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The briefing can be accessed live by calling 855.493.3607 or 346.354.0950 for international callers (ID#: 9599904) or at the following address on the company’s website: investor.mylan.com. A replay of the webcast also will be available on the website.